Kongchang Wei

Dr. Kongchang Wei

Empa, Swiss Federal Laboratories for Materials Science and Technology, Laboratory for Biomimetic Membranes and Textiles, Lerchenfeldstrasse 5, 9014 St. Gallen, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Chemical Reviews
Verified
Journal Article
Closed access
LSLu Su
Lu Su
YFYingle Feng
Yingle Feng
Kongchang WeiKongchang Wei
Kongchang Wei
XXXuyang Xu
Xuyang Xu
RLRongying Liu
Rongying Liu
GCGuosong Chen
Guosong Chen


10 September 2013 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
YZYu Zhao
Yu Zhao
FSFuji Sakai
Fuji Sakai
LSLu Su
Lu Su
YLYijiang Liu
Yijiang Liu
Kongchang WeiKongchang Wei
Kongchang Wei
MJMing Jiang
Ming Jiang


26 August 2020 in Science Translational Medicine
Verified
Journal Article
Closed access
XXXiayi Xu
Xiayi Xu
XXXianfeng Xia
Xianfeng Xia
Kunyu ZhangKunyu Zhang
Kunyu Zhang
ARAliza Rai
Aliza Rai
ZLZhuo Li
Zhuo Li
Liming BianLiming Bian
Liming Bian
Bioadhesive hydrogel with ultrafast gelation independent of environmental pH is endoscopically delivered to enhance gastric ulcer healing.

13 February 2019 in ACS Central Science
Verified
Journal Article
Open access
QFQian Feng
Qian Feng
JXJiankun Xu
Jiankun Xu
Kunyu ZhangKunyu Zhang
Kunyu Zhang
HYHao Yao
Hao Yao
NZNianye Zheng
Nianye Zheng
Liming BianLiming Bian
Liming Bian
Biopolymeric hydrogels have been widely used as carriers of therapeutic cells and drugs for biomedical applications. However, most conventional hydrogels cannot be injected after gelation and do not support the infiltration of cells because of the static nature of their network structure. Here, we develop unique cell-infiltratable and injectable (Ci-I) gelatin hydrogels, which are physically cross-linked by weak and highly dynamic host–guest complexations and are further reinforced by limited chemical cross-linking for enhanced stability, and then demonstrate the outstanding properties of these Ci-I gelatin hydrogels. The highly dynamic network of Ci-I hydrogels allows injection of prefabricated hydrogels with encapsulated cells and drugs, thereby simplifying administration during surgery. Furthermore, the reversible nature of the weak host–guest cross-links enables infiltration and migration of external cells into Ci-I gelatin hydrogels, thereby promoting the participation of endogenous cells in the healing process. Our findings show that Ci-I hydrogels can mediate sustained delivery of small hydrophobic molecular drugs (e.g., icaritin) to boost differentiation of stem cells while avoiding the adverse effects (e.g., in treatment of bone necrosis) associated with high drug dosage. The injection of Ci-I hydrogels encapsulating mesenchymal stem cells (MSCs) and drug (icaritin) efficiently prevented the decrease in bone mineral density (BMD) and promoted in situ bone regeneration in an animal model of steroid-associated osteonecrosis (SAON) of the hip by creating the microenvironment favoring the osteogenic differentiation of MSCs, including the recruited endogenous cells. We believe that this is the first demonstration on applying injectable hydrogels as effective carriers of therapeutic cargo for treating dysfunctions in deep and enclosed anatomical sites via a minimally invasive procedure.